Blepharonasofacial malformation syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1252OMIM:110050Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Blepharonasofacial malformation syndrome (BNFMS), also known as Pashayan syndrome, is an extremely rare congenital disorder characterized by a distinctive combination of facial, nasal, and eyelid abnormalities. The condition was first described by Pashayan and colleagues in 1973. Key clinical features include telecanthus (widely spaced inner corners of the eyes), a broad and flat nasal bridge, S-shaped or laterally deviated nostrils, mask-like facial appearance with midface hypoplasia, and blepharophimosis (narrowing of the eye openings). Additional features may include a trapezoidal upper lip, torsion of the nose, and soft doughy skin. Some affected individuals may also present with mild intellectual disability, short stature, and hand anomalies such as brachydactyly or clinodactyly. The syndrome primarily affects craniofacial structures, including the eyelids, nose, and midface region. Skeletal and dermatologic systems may also be involved. The condition is present from birth, and the characteristic facial features are typically recognizable in the neonatal or early infantile period. There is no specific curative treatment for blepharonasofacial malformation syndrome. Management is supportive and symptomatic, potentially involving surgical correction of eyelid or nasal abnormalities, developmental support for those with intellectual disability, and regular monitoring of growth. Genetic counseling is recommended for affected families. Due to the extreme rarity of this condition, clinical knowledge is based on a very limited number of reported cases in the medical literature.

Also known as:

Clinical phenotype terms— hover any for plain English:

Lacrimation abnormalityHP:0000632Torsion dystoniaHP:0001304
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Blepharonasofacial malformation syndrome.

View clinical trials →

No actively recruiting trials found for Blepharonasofacial malformation syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Blepharonasofacial malformation syndrome community →

No specialists are currently listed for Blepharonasofacial malformation syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Blepharonasofacial malformation syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Blepharonasofacial malformation syndromeForum →

No community posts yet. Be the first to share your experience with Blepharonasofacial malformation syndrome.

Start the conversation →

Latest news about Blepharonasofacial malformation syndrome

No recent news articles for Blepharonasofacial malformation syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Blepharonasofacial malformation syndrome

What is Blepharonasofacial malformation syndrome?

Blepharonasofacial malformation syndrome (BNFMS), also known as Pashayan syndrome, is an extremely rare congenital disorder characterized by a distinctive combination of facial, nasal, and eyelid abnormalities. The condition was first described by Pashayan and colleagues in 1973. Key clinical features include telecanthus (widely spaced inner corners of the eyes), a broad and flat nasal bridge, S-shaped or laterally deviated nostrils, mask-like facial appearance with midface hypoplasia, and blepharophimosis (narrowing of the eye openings). Additional features may include a trapezoidal upper lip

How is Blepharonasofacial malformation syndrome inherited?

Blepharonasofacial malformation syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Blepharonasofacial malformation syndrome typically begin?

Typical onset of Blepharonasofacial malformation syndrome is neonatal. Age of onset can vary across affected individuals.